Published in Immun Ageing on December 02, 2011
Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance. Hepatology (2016) 0.86
Epstein-barr virus as a trigger of autoimmune liver diseases. Adv Virol (2012) 0.81
p38 MAPK Signaling in Pemphigus: Implications for Skin Autoimmunity. Autoimmune Dis (2013) 0.81
Sex differences associated with primary biliary cirrhosis. Clin Dev Immunol (2012) 0.80
Changing trends of hospitalisation of liver cirrhosis in Beijing, China. BMJ Open Gastroenterol (2015) 0.77
Autoantibodies in autoimmune pancreatitis. Int J Rheumatol (2012) 0.77
The X-factor in primary biliary cirrhosis: monosomy X and xenobiotics. Auto Immun Highlights (2012) 0.75
Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies. Auto Immun Highlights (2012) 0.75
Tuberculosis is not a risk factor for primary biliary cirrhosis: a review of the literature. Tuberc Res Treat (2012) 0.75
Popular and unpopular infectious agents linked to primary biliary cirrhosis. Auto Immun Highlights (2012) 0.75
Primary biliary cirrhosis is a generalized autoimmune epithelitis. Int J Mol Sci (2015) 0.75
Autophagy in the pathogenesis of disease. Cell (2008) 34.68
Autophagy: process and function. Genes Dev (2007) 15.21
Cellular senescence in cancer and aging. Cell (2007) 9.04
Primary biliary cirrhosis. N Engl J Med (2005) 7.59
Immunosuppressive effects of apoptotic cells. Nature (1997) 7.03
Primary biliary cirrhosis. Hepatology (2009) 5.35
Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell (2003) 3.68
Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum (1998) 3.41
Natural history of early primary biliary cirrhosis. Lancet (1996) 3.24
T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 3.06
The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol (2010) 2.93
Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol (2001) 2.78
Apoptosis in resolution of inflammation. J Leukoc Biol (1997) 2.67
CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol (2009) 2.66
Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum (2002) 2.52
The causes of primary biliary cirrhosis: Convenient and inconvenient truths. Hepatology (2008) 2.32
Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31
Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe (2008) 2.30
CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev (2005) 2.16
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology (2005) 2.15
Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis. J Hepatol (2008) 2.04
Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ (1999) 2.02
Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology (2006) 1.98
In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum (1997) 1.95
Autophagy in the liver. Hepatology (2008) 1.84
Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum (2006) 1.83
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology (2002) 1.77
Premature aging of the immune system in children with juvenile idiopathic arthritis. Arthritis Rheum (2008) 1.71
Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology (2007) 1.68
Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology (2004) 1.67
Nucleosomes are exposed at the cell surface in apoptosis. J Immunol (2004) 1.66
Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci U S A (2003) 1.65
Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev (2005) 1.65
Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci U S A (2003) 1.64
Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? Gastroenterology (2006) 1.64
HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med (1995) 1.61
The role of environmental factors in primary biliary cirrhosis. Trends Immunol (2009) 1.61
Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology (2009) 1.55
Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol (2004) 1.54
The evidence does not support a viral etiology for primary biliary cirrhosis. J Hepatol (2010) 1.53
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology (2010) 1.53
Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis. J Hepatol (2000) 1.53
Shortening of telomeres: Evidence for replicative senescence of T cells derived from patients with Wegener's granulomatosis. Kidney Int (2003) 1.52
Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest (1998) 1.52
Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ (2007) 1.50
Primary biliary cirrhosis: an epidemiological study. Br Med J (1980) 1.48
Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology (2010) 1.47
Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol (2005) 1.47
Primary biliary cirrhosis. Semin Immunopathol (2009) 1.46
Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology (2003) 1.46
IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun (2006) 1.43
Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest (2001) 1.40
Risk factors for primary biliary cirrhosis in a cohort of patients from the united states. Hepatology (2001) 1.37
Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol (2008) 1.34
Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? Hepatology (1987) 1.32
Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology (2005) 1.28
Primary biliary cirrhosis. Lancet (1997) 1.27
Aging, immunity and cancer. Curr Opin Immunol (2004) 1.27
Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum (2008) 1.25
Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol (2004) 1.24
Virus, liver and autoimmunity. Dig Liver Dis (2001) 1.24
Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol (2002) 1.24
In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology (1997) 1.20
Bacteriuria and primary biliary cirrhosis. Gut (1984) 1.20
Eating to exit: autophagy-enabled senescence revealed. Genes Dev (2009) 1.20
Estrogens and the pathophysiology of the biliary tree. World J Gastroenterol (2006) 1.20
Urinary tract infections in the elderly population. Am J Geriatr Pharmacother (2011) 1.17
Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology (2002) 1.15
Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun (2005) 1.13
Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med (1995) 1.11
Clearance deficiency--a potential link between infections and autoimmunity. Autoimmun Rev (2008) 1.09
Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest (1993) 1.09
Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations. Gut (2010) 1.07
The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun (2010) 1.07
M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol (1993) 1.07
Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut (2005) 1.07
Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology (1997) 1.07
Progress in the genetics of primary biliary cirrhosis. Semin Liver Dis (2011) 1.07
Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol (2004) 1.06
Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology (1991) 1.06
Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis. J Pathol (2001) 1.05
Ageing, autoimmunity and arthritis: Perturbations of TCR signal transduction pathways with ageing - a biochemical paradigm for the ageing immune system. Arthritis Res Ther (2003) 1.05
Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet (1989) 1.05
Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology (2000) 1.04
Bacteria and human autoimmunity: the case of primary biliary cirrhosis. Curr Opin Rheumatol (2004) 1.04
Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology (2005) 1.03
The immunological milieu of the liver. Semin Liver Dis (2007) 1.03
Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology (2006) 1.03
Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatology (2008) 1.03
T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun (2007) 1.03
Disease-specific autoantibodies in primary biliary cirrhosis. Clin Chim Acta (2010) 1.03
Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis (2009) 1.02
Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis. Am J Pathol (2006) 1.02
Increased incidence of menstrual abnormalities and hysterectomy preceding primary biliary cirrhosis. Br Med J (Clin Res Ed) (1986) 1.02
Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis. Lab Invest (2010) 1.01
Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. J Hepatol (2010) 1.01
Pathogenesis of autoimmune hepatitis. Clin Liver Dis (2002) 1.00
New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem (2009) 0.99
Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss. J Pathol (2005) 0.99
Treating autoimmune disease by targeting CD8(+) T suppressor cells. Expert Opin Biol Ther (2009) 0.98
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology (2004) 2.64
Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease. Clin Chim Acta (2010) 2.31
Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis. Dig Dis Sci (2014) 2.06
Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism. Gut (2011) 1.91
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet (2013) 1.83
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology (2002) 1.77
Occult hepatitis B virus infection in patients with autoimmune liver diseases. Liver Int (2008) 1.76
Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology (2007) 1.68
Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology (2004) 1.67
Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? Gastroenterology (2006) 1.64
Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations. J Hepatol (2009) 1.62
Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives. Am J Gastroenterol (2004) 1.57
Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients. J Hepatol (2011) 1.56
Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology (2009) 1.55
Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol (2004) 1.54
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology (2010) 1.53
Macrophage plasticity and polarization in liver homeostasis and pathology. Hepatology (2014) 1.48
Genes and goals: an approach to microarray analysis in autoimmunity. Autoimmun Rev (2005) 1.48
Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun (2011) 1.48
Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology (2003) 1.46
Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun (2009) 1.41
Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology (2002) 1.41
MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. Autoimmun Rev (2010) 1.37
Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol (2008) 1.34
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet (2012) 1.32
The consequences of apoptosis in autoimmunity. J Autoimmun (2008) 1.24
The X chromosome and immune associated genes. J Autoimmun (2011) 1.24
Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol (2004) 1.24
A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology (2007) 1.23
Interferon alpha and its contribution to autoimmunity. Curr Opin Investig Drugs (2006) 1.21
New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun (2008) 1.21
Definition of human autoimmunity--autoantibodies versus autoimmune disease. Autoimmun Rev (2009) 1.20
Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. Cancer Res (2008) 1.18
Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology (2006) 1.15
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun (2010) 1.13
Transmission and pathogenicity of encephalomyocarditis virus (EMCV) among rats. Vet Res (2004) 1.13
Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun (2005) 1.13
Glycoprotein 2 antibodies in inflammatory bowel disease: no association with disease phenotype? J Pediatr Gastroenterol Nutr (2013) 1.12
Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun (2007) 1.12
The immunological potential of galectin-1 and -3. Autoimmun Rev (2008) 1.11
Type 1 autoimmune pancreatitis. Orphanet J Rare Dis (2011) 1.10
Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology. Semin Liver Dis (2005) 1.10
Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology (2007) 1.10
Interpreting serological tests in diagnosing autoimmune liver diseases. Semin Liver Dis (2007) 1.10
Anti-GP2 antibodies in inflammatory bowel disease patients with ileal pouch. J Crohns Colitis (2013) 1.09
Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse. J Autoimmun (2013) 1.08
Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity. Hepatology (2009) 1.08
Progress in the genetics of primary biliary cirrhosis. Semin Liver Dis (2011) 1.07
Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells. Hepatology (2014) 1.06
New platform technology for comprehensive serological diagnostics of autoimmune diseases. Clin Dev Immunol (2012) 1.04
Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology (2005) 1.03
Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology (2006) 1.03
The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. J Autoimmune Dis (2007) 1.02
Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C. J Hepatol (2010) 1.02
Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies. Autoimmun Rev (2011) 1.01
Pathogenesis of autoimmune hepatitis. Clin Liver Dis (2002) 1.00
B cell depletion therapy exacerbates murine primary biliary cirrhosis. Hepatology (2010) 0.99
Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis. Ann Intern Med (2007) 0.98
A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun (2009) 0.98
Viral/self-mimicry and immunological cross-reactivity as a trigger of hepatic C virus associated autoimmune diabetes. Diabetes Res Clin Pract (2006) 0.97
Autoimmunity and Turner's syndrome. Autoimmun Rev (2011) 0.96
Iron levels in polarized macrophages: regulation of immunity and autoimmunity. Autoimmun Rev (2012) 0.96
Etiopathogenesis of primary biliary cirrhosis. World J Gastroenterol (2008) 0.96
PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease. Clin Chim Acta (2013) 0.96
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis. Hepatology (2013) 0.96
Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol (2005) 0.96
Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol (2003) 0.95
Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases. Autoimmun Rev (2012) 0.95
Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: its synthesis is reduced favoring cholangiocarcinoma growth. Am J Physiol Gastrointest Liver Physiol (2011) 0.94
Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis. Hepatology (2011) 0.94
The limitations and hidden gems of the epidemiology of primary biliary cirrhosis. J Autoimmun (2013) 0.94
A cross-sectional study of Leishmania spp. infection in clinically healthy dogs with polymerase chain reaction and serology in Greece. Vet Parasitol (2002) 0.94
Towards common denominators in primary biliary cirrhosis: the role of IL-12. J Hepatol (2011) 0.93
Evaluation of lymph node and bone marrow cytology in the diagnosis of canine leishmaniasis (Leishmania infantum) in symptomatic and asymptomatic dogs. Am J Trop Med Hyg (2005) 0.93
Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J Clin Immunol (2007) 0.93
Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece. World J Gastroenterol (2010) 0.92
Geoepidemiology, gender and autoimmune disease. Autoimmun Rev (2011) 0.92
Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology (2011) 0.92
Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found. Autoimmun Rev (2012) 0.92
Salmonella enteritidis Infection Complicated by Acute Myocarditis: A Case Report and Review of the Literature. Cardiol Res Pract (2011) 0.92
Epidemiology and pathogenesis of primary biliary cirrhosis. J Clin Gastroenterol (2004) 0.92
Y chromosome loss in male patients with primary biliary cirrhosis. J Autoimmun (2013) 0.92
Autoimmunity and environment: am I at risk? Clin Rev Allergy Immunol (2012) 0.91
Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol (2009) 0.91
IgA anti-b2GPI antibodies in patients with autoimmune liver diseases. J Clin Immunol (2008) 0.91
Increased local dopamine secretion has growth-promoting effects in cholangiocarcinoma. Int J Cancer (2010) 0.91
Cytologic patterns of lymphadenopathy in dogs infected with Leishmania infantum. Vet Clin Pathol (2005) 0.90
Effect of anti-carbonic anhydrase antibodies on carbonic anhydrases I and II. Clin Chem (2003) 0.90
Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis. Epigenetics (2011) 0.90